Literature DB >> 26296199

Parkinson's disease psychosis: symptoms, management, and economic burden.

Neal Hermanowicz, Kari Edwards.   

Abstract

Parkinson’s disease psychosis (PDP) is a costly,debilitating condition that generally develops several years after diagnosis of Parkinson’s disease (PD).PD is the second-most common neurodegenerative disease, and it imposes a significant burden on the healthcare system. Non-motor symptoms commonly manifest in PD, contributing to the severity of a patient’s disability. The neuropsychiatric symptoms that are common in PD can be a significant source of distress to patients and caregivers. Recent studies have shown that more than 50% of patients with PD will develop psychosis at some time over the course of the disease. The responsibility for caring for a person with PDP frequently falls on family members. Caregiver distress is frequently predicted when patients with PD have symptoms of psychosis.Hallucinations and delusions are independent predictors of nursing home placement for patients with PDP. The authors sought to examine total healthcare expenditures among patients with PDP compared with patients with PD without psychosis.All costs were higher for patients with PDP than for those with PD without psychosis and all-Medicare cohorts, with the highest cost differentials found in long-term care costs ($31,178 for PDP vs $14,461 forPD without psychosis), skilled nursing facility costs($6601 for PDP vs $2067 for PD without psychosis),and inpatient costs ($10,125 for PDP vs $6024 for PD without psychosis). Patients with PDP spent an average of 179 days in long-term care, compared with 83 days for patients with PD without psychosis. As expected, long-term care utilization and expenditures were significantly higher for patients with PDP than for patients with PD without psychosis. Reducing long-term care utilization by patients with PDP may significantly lower the overall economic burden associated with PDP.

Entities:  

Mesh:

Year:  2015        PMID: 26296199

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  7 in total

1.  New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson's Disease.

Authors:  Michael A Kelberman; Elena M Vazey
Journal:  Curr Pharmacol Rep       Date:  2016-09-28

2.  Parkinson's Disease Caregiver Strain in Singapore.

Authors:  Siok-Bee Tan; Allison F Williams; Eng-King Tan; Richard B Clark; Meg E Morris
Journal:  Front Neurol       Date:  2020-06-23       Impact factor: 4.003

3.  Treatment of psychotic symptoms in patients with Parkinson disease.

Authors:  Jack J Chen
Journal:  Ment Health Clin       Date:  2018-03-23

4.  Atypical antipsychotics for Parkinson's disease psychosis: a systematic review and meta-analysis.

Authors:  Han Zhang; Limin Wang; Yafei Fan; Lianhong Yang; Xiaojun Wen; Yunyun Liu; Zhonglin Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-29       Impact factor: 2.570

5.  Pimavanserin Treatment for Parkinson's Disease Psychosis in Clinical Practice.

Authors:  Khashayar Dashtipour; Fiona Gupta; Robert A Hauser; Cherian A Karunapuzha; John C Morgan
Journal:  Parkinsons Dis       Date:  2021-01-04

6.  Neuropsychiatric Symptoms in Parkinson's Disease Patients Are Associated with Reduced Health-Related Quality of Life and Increased Caregiver Burden.

Authors:  Hannah von Eichel; Johanne Heine; Florian Wegner; Sophia Rogozinski; Stephanie Stiel; Adrian Groh; Lea Krey; Günter U Höglinger; Martin Klietz
Journal:  Brain Sci       Date:  2022-01-11

7.  Direct Medical Costs of Parkinson's Disease in Southern China: A Cross-Sectional Study Based on Health Insurance Claims Data in Guangzhou City.

Authors:  Hui Zhang; Wenjing Zhou; Donglan Zhang
Journal:  Int J Environ Res Public Health       Date:  2022-03-09       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.